Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters

Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year

It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts

Topic |   Pharmaceuticals

TOP PICKS

Chinese investors are investing heavily in US drug start-ups, adding to a flood of cash flowing to groundbreaking health firms. Pictured are US dollar and China yuan notes. Photo illustration: Reuters
READ FULL ARTICLE